According to Chilean doctor, immunotherapy can prevent deaths from colorectal cancer | L & # 39; UNIVERSAL



[ad_1]

The lives of thousands of people that colorectal cancer takes a year in the world can be significantly reduced through early detection and immunotherapy, said pathologist and molecular oncologist Ramon Gutiérrez

"The Advanced treatments for immunotherapies can provide a better quality of life for patients and improve up to 40 percent the results of traditional treatments, "said Dr. Gutierrez, who is also executive director of the Biogenic-Recell Medical Center. [19659002] The professional explained that usually patients receive chemotherapy treatment after an extirpation surgery, sometimes accompanied by radiotherapy, after which it is very important that the patient adds as soon as possible a treatment of 39 high performance dendritic cell immunotherapy, consulting the appropriate specialist in molecular oncology and Immuno-oncology

In this sense, Dr. Gutierrez z noted that in patients with "colon adenocarcinoma and melanoma, among others, in cases with initial survival expectations of about four months, they exceeded two years, with an adequate quality of life ".

without proposing any treatment and only with the possibility of palliative care, they decided to initiate immunotherapy and thus reduce by about 40% the tumor metabolic activity badessed by CT emission tomography. positron (PET) 60 days after After immunotherapy, he said:

In Chile, data provided by the Ministry of Health indicate that colorectal cancer is the third leading cause of death among women and the fourth in men, five people die every day. Worldwide, this disease takes the lives of 700,000 people each year, according to the World Health Organization (WHO).

In fact, statistics show that over the past decade, deaths from this type of cancer have increased by 116% and it is estimated that by 2020 they will increase by 50%.

Colorectal cancer is characteristic of developed countries. For example, in the United States, it is expected that this year there will be about 50 deaths due to this disease, according to statistics from the American Cancer Society. Developed countries have rates of 20 cases per 100,000 population and Chile has about 10 cases for the same number of inhabitants as it is still developing.

million. Gutiérrez explained that the reasons for which one can produce This type of cancer is varied and some factors can increase the possibilities such as age, diet, genetics and lifestyle.

Therefore, the doctors emphasize the importance of performing preventive examinations, able to detect early stage disease, thanks to prevention campaigns specific to certain centers, for a month, for different types of cancer all over the world. throughout the year.

Once the cancer is detected, the treatment options vary depending on the stage of the tumor, how deep it is in the intestinal wall or in other tissues and where it is located ( colon or rectum).

According to the profession, the center of Biogen-Recell, located in the city of Concepción, 515 kilometers south of the Chilean capital, is one of the first centers of oncology in the country to have developed biological treatments against cancer.

These are custom protocols that fight or eliminate cancer cells, preventing even their reoccurrence after treatment, since they create an immunological memory for years.

"These applications are developed from cells extracted from the tumor itself, occupied in the laboratory to reprogram cells obtained from the patient's blood, called dendritic cells, and then reintroduced into the patient's body", explains the Dr. José Carlos Castillo, director of ReCell

Castillo adds that the experts indicate, and his trajectory confirms "that what is interesting because of this, the treatment, especially the third generation protocol, has been revealed safe , non-invasive for the patient. On the other hand, it is an alternative treatment, in combination with chemotherapy and / or radiotherapy, and even with other mechanisms of immunotherapy such as antibodies or inhibitors of checkpoint, which "provides a better quality of life for the patient, even increasing his survival by 325%."

[ad_2]
Source link